Cement Grinding Plant News
  1. Home >
  2. News >
  3. Ajanta Pharma Announcement

Ajanta Pharma Announcement

Ajanta pharma ltd made a public announcement the public announcement to the buyback as defined hereinafter pursuant to the provisions of regulation 7i and other applicable provisions of the securities and exchange board of india buyback of securities regulations, 2018, as amended the buyback regulations for the time being in force including any statutory modifications.

Live Chat
  • Ajanta Pharma Ltd. Disclosures Under Reg. 31(1) And
    Mar
    Ajanta Pharma Ltd. Disclosures Under Reg. 31(1) And

    18 hours ago 03:22 pm. the exchange has received disclosure under regulation 31 (1) and 31 (2) of sebi (substantial acquisition of shares amp; takeovers) regulations, 2011 on novem for ravi agrawal,trustee ravi agrawal trust. view all announcements for ajanta pharma ltd.

    Get Price>
  • Psu Banks Are Up For Solid Run Up After Announcement Of
    Mar
    Psu Banks Are Up For Solid Run Up After Announcement Of

    2 days ago disclaimer : the views expressed in the forum are the views of the user writing the post, and not that of agree, by accessing this forum, that bears no liability for any posts on this forum or, any losses suffered by following any advice posted on this operates this real time, open, unmoderated, private forum for users to.

    Get Price>
  • Welcome To Ajanta Pharma Limited.
    Jul
    Welcome To Ajanta Pharma Limited.

    Ajanta pharma limited advertisement. letter of offer. tender form physical. tender form demat. form sh4. draft letter of offer. public announcement. board resolution for buyback. outcome of board meeting regarding buyback. intimation of buy back of shares. tender form physical. tender form demat. letter of offer.

    Get Price>
  • Ajanta Pharma Limited Rb Company Profile
    Jan
    Ajanta Pharma Limited Rb Company Profile

    Ajanta pharma limited conference call transcript, ajanta pharma limited management interviews, ajanta pharma limited investor presentations, ajanta pharma limited annual reports, ajanta pharma limited articles, ajanta pharma limited press release, ajanta pharma limited agmegmboard meetings, ajanta pharma limited results, ajanta pharma limited credit.

    Get Price>
  • Ajanta Pharma Ltd. Conference Calls, Earnings Call
    Sep
    Ajanta Pharma Ltd. Conference Calls, Earnings Call

    Ajanta pharma ltd 532331 announcement under regulation 30 (lodr)earnings call transcript bse india pursuant to regulation 30 of the sebi (listing obligations and disclosure requirements ) regulations 2015, we are enclosing herewith the schedule of earnings conference call to be held on 29th july 2021, post board meeting.

    Get Price>
  • Ajanta Pharma Ltd Latest Corporate Announcements
    Jan
    Ajanta Pharma Ltd Latest Corporate Announcements

    Ajanta pharma ltd latest corporate news amp; announcements, be updated on the live and latest happenings in ajanta pharma ltd with the fastest amp; most reliable source.

    Get Price>
  • Ajanta Pharma Ltd. Results Performance, Latest
    Jul
    Ajanta Pharma Ltd. Results Performance, Latest

    Ajanta pharma ltd. quarterly results, financial performance and trends. markets results mutual funds famp;o reports screeners subscribe superstars portfolio watchlist alerts insider trading amp; sast what's new. overview. financials. news.

    Get Price>
  • Ajanta Pharma Ltd Sharestock Price Amp; Analysis, Live Nse
    Oct
    Ajanta Pharma Ltd Sharestock Price Amp; Analysis, Live Nse

    Ajanta pharma informed bse that the meeting of the board of directors of the company is scheduled on 03112020 ,inter alia, to consider and approve pursuant to regulation 29 of the listing regulations, we hereby inform that a meeting of the board of directors of the company will be held on tuesday, 3rd november 2020 to interalia: 1.

    Get Price>
  • Ajanta Pharma Ltd. : Bse Corporate Announcements
    Oct
    Ajanta Pharma Ltd. : Bse Corporate Announcements

    Ajanta pharma informed bse that the meeting of the board of directors of the company is scheduled on 29102021 ,inter alia, to consider and approve pursuant to regulation 29 of the listing regulations, we hereby inform that a meeting of the board of directors of the company will be held on friday, 29th october 2021 to interalia: 1.

    Get Price>
  • Ajanta Pharma Usa Inc
    Feb
    Ajanta Pharma Usa Inc

    Ajanta pharma usa inc., based in bridgewater, new jersey, is a wholly owned subsidiary of ajanta pharma ltd. ajanta pharma is committed to delivering quality generic drugs to patients, through collaboration with its industry partners. ajanta pharma is dedicated to superior service, supply chain reliability and flexibility to meet the unique.

    Get Price>
  • Ajanta Pharma: Reports, Company History, Directors Report
    Oct
    Ajanta Pharma: Reports, Company History, Directors Report

    Ajanta pharma's news and announcements. all; news; announcements; us fda inspection of our dahej facility. by bse on 27 jul 2018 | 12:28 pm. disclosures under reg. 31(1) and 31(2) of.

    Get Price>
  • Ajanta Pharma Announcements Business Standard
    Mar
    Ajanta Pharma Announcements Business Standard

    Announcement for ajanta pharma ltd ajanta pharma ltd disclosures under reg. 31(1) and 31(2) of sebi (sast) regulations 2011. 17112021 | bse | downlaod pdf.

    Get Price>
  • Ajanta Pharma Share Price : Live Nsebse Stock Price Today
    Aug
    Ajanta Pharma Share Price : Live Nsebse Stock Price Today

    Announcement under regulation 30 (lodr)earnings call transcript. ajanta pharma limited analystsinstitutional investor meetcon. call updates. ajanta pharma limited analystsinstitutional investor meetcon. call updates. announcement under regulation 30 (lodr)newspaper publication. audio recording of earnings call conducted on 29th.

    Get Price>
  • Ajanta Pharma Buyback 2020 Details: Buy Back
    Apr
    Ajanta Pharma Buyback 2020 Details: Buy Back

    Ajanta pharma buyback offer amount: ₹ 135. date of board meeting approving the proposal: . date of public announcement: . ajanta pharma buyback offer size: 0.84. buyback number of shares:.

    Get Price>
  • Ajanta Pharma Ltd. 532331 Announcement Under
    Apr
    Ajanta Pharma Ltd. 532331 Announcement Under

    Ajanta pharma ltd. 532331 announcement under regulation 30 (lodr)newspaper publication bse india pursuant to regulation 47 of the listing regulations, please find enclosed copies of financial results of the company for the quarter ended 31st december 2020 published in following newspapers on 3rd february 2021: 1.

    Get Price>
  • Ajanta Pharma (3Qfy21): Poised To Rerate. Maintain Buy
    Aug
    Ajanta Pharma (3Qfy21): Poised To Rerate. Maintain Buy

    Ajanta pharma ltd. ajanta pharma (3qfy21): poised to rerate. maintain buy. maintain buy, risks: we increase our eps estimate by 10 for fy21e to factor the q3 beat and by 34 for fy2223e on the back of improved growth visibility for the branded business. we revise our tp upwards to inr 2,250sh, based on 23x fy23e eps.

    Get Price>
  • Welcome To Ajanta Pharma Limited.
    Nov
    Welcome To Ajanta Pharma Limited.

    Intimation of board meeting q1 2018 amp; trading window closure. notice of 41st agm. press release promoters sell small stake in ajanta pharma. notice of book closure and evoting for 40th agm. intimation of options granted. voting results amp; scrutinizer's results of 38th agm. notice, attendance slip and proxy form of 40th agm.

    Get Price>
  • Latest Ajanta Pharma Ltd News, Photos, Latest News
    May
    Latest Ajanta Pharma Ltd News, Photos, Latest News

    Latest ajanta pharma ltd news and updates, special reports, videos amp; photos of ajanta pharma ltd on the hindu businessline. articles on ajanta pharma ltd, complete coverage on ajanta pharma ltd.

    Get Price>
  • Ajanta Pharma Announces The Launch Of Levetiracetam Tablets
    Aug
    Ajanta Pharma Announces The Launch Of Levetiracetam Tablets

    Ajanta pharma announces the launch of levetiracetam tablets. bridgewater, n.j., ma prnewswire ajanta pharma usa inc., a wholly owned subsidiary of ajanta pharma ltd, announces.

    Get Price>
  • Ajanta Pharma Limited : Company Events Publications
    Sep
    Ajanta Pharma Limited : Company Events Publications

    080421 : q1 2022 earnings release (projected) 110321 : interim 2022 earnings release (projected) 020122 : q3 2022 earnings release (projected) 050422.

    Get Price>
  • Mutual Fund Oct 2021 Share Holdings And Fund Action In
    Jun
    Mutual Fund Oct 2021 Share Holdings And Fund Action In

    My corporate announcements my stock news 12 mfs bought and 8 mfs sold ajanta pharma ltd. in the month of oct 2021 for a net change of 94,465 stocks number of mfs buying, holding, selling. mf shareholding and changes. uti flexi cap fund regular plan growth was the highest buyer of 74,391 shares in oct 2021 constituting 0.09 of the paid up.

    Get Price>
  • Ajanta Pharma Dividend 2020: Latest News Record Date
    Nov
    Ajanta Pharma Dividend 2020: Latest News Record Date

    Ajanta pharma dividend 2020: ajanta pharma dividend record date, history, payment date, payment date, payout date, dividend history, interim amp; final dividend per share. ajanta pharma announced its q2 september 2020 results yesterday (3 november). on a consolidated basis, the companys net profit increased 46.29 to rs 170.22 crore on a 11.38 rise in revenue from.

    Get Price>
  • Ajanta Pharma Limited Public Announcement Buyback
    Jan
    Ajanta Pharma Limited Public Announcement Buyback

    Ajanta pharma limited public announcement buyback of shares ajanta pharma limited has informed the exchange about public announcement buyback of shares.

    Get Price>
  • Ajanta Pharma Ltd Buyback 2020, Buyback Price With
    Feb
    Ajanta Pharma Ltd Buyback 2020, Buyback Price With

    Ajanta pharma ltd made a public announcement (the public announcement) to the buyback (as defined hereinafter) pursuant to the provisions of regulation 7(i) and other applicable provisions of the securities and exchange board of india (buyback of securities) regulations, 2018, as amended (the buyback regulations) for the time being in force including any statutory modifications.

    Get Price>
  • Ajanta Pharma Ltd. Announcement Under Regulation
    Dec
    Ajanta Pharma Ltd. Announcement Under Regulation

    Ajanta pharma ltd. announcement under regulation 30 (lodr)earnings call transcript rediff moneywiz, the personal finance service from equips the user with tools and information in the form of graphs, charts, expert advice, and more to stay upto.

    Get Price>
  • Ajanta Pharma Standalone September 2021 Net Sales At Rs
    May
    Ajanta Pharma Standalone September 2021 Net Sales At Rs

    Ajanta pharma shares closed at 2,188.30 on novem (nse) and has given 17.37 returns over the last 6 months and 35.62 over the last 12 months. ajanta pharma standalone quarterly results.

    Get Price>
  • Ajanta Pharma Dividend 2020 With Record, Payment Detail
    Jun
    Ajanta Pharma Dividend 2020 With Record, Payment Detail

    Ajanta pharma announced its q2 september 2020 results yesterday (3 november). on a consolidated basis, the companys net profit increased 46.29 to rs 170.22 crore on a 11.38 rise in revenue from operations to rs 715.91 crore in q2 september 2020 over q2 september before tax (pbt) jumped 54.27 to rs 249.24 crore in.

    Get Price>
  • Ajanta Pharma Ltd. Share Price | Ratios | Bsense
    Dec
    Ajanta Pharma Ltd. Share Price | Ratios | Bsense

    21 november 2021, 05:57. add ajanta pharma, target price rs 2440: hdfc securities 01 nov 2021. ajanta pharma share price up by 5; bse healthcare index up 0.8 29 sep 2021. divis laboratories at all time high; bse healthcare index up 1.8 04 oct 2021. bse announcements from ajanta pharma ltd.

    Get Price>
  • Ajanta Pharma Ltd. Announcementsnotices: Latest Sotck
    Feb
    Ajanta Pharma Ltd. Announcementsnotices: Latest Sotck

    Ajanta pharma ltd. announcementsnotices: get latest noticesannouncements on ajanta pharma ltd., bsense corporate announcementsnotices on ajanta pharma ltd., ajanta pharma ltd. stock split.

    Get Price>
  • Ajanta Pharma Fixes Record Date For Interim Dividend
    May
    Ajanta Pharma Fixes Record Date For Interim Dividend

    Ajanta pharma ltd has informed bse that the company has fixed novem as the record date for the purpose of payment of interim dividend, if.

    Get Price>
toTop